Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Lukasz Laczmanski"'
Autor:
Monika Stępień, Małgorzata Zalewska, Brygida Knysz, Natalia Świątoniowska-Lonc, Beata Jankowska-Polańska, Łukasz Łaczmański, Agnieszka Piwowar, Amadeusz Kuźniarski
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1042 (2022)
Since the end of December 2020, it has been possible to vaccinate against COVID-19. Our aim was to evaluate and compare the effectiveness of the vaccines available at the time of the mass vaccination program in Poland and also to look into the most c
Externí odkaz:
https://doaj.org/article/5a35501041c440e287df287cd3482c90
Autor:
Monika Maria Biernat, Aldona Bińkowska, Łukasz Łaczmański, Paweł Biernat, Paweł Krzyżek, Grażyna Gościniak
Publikováno v:
Diagnostics, Vol 10, Iss 10, p 759 (2020)
Antibiotic resistance of Helicobacter pylori is currently a global issue. The aim of this study was to analyze actual antibiotic resistance rates of H. pylori strains isolated from children with primary infections and to compare the incidence of muta
Externí odkaz:
https://doaj.org/article/0d04ec28f83a4da1ad94e89ced23b7ba
Autor:
Paweł Krzyżek, Roman Franiczek, Barbara Krzyżanowska, Łukasz Łaczmański, Paweł Migdał, Grażyna Gościniak
Publikováno v:
Pathogens, Vol 8, Iss 4, p 228 (2019)
Antibiotic resistance of Helicobacter pylori, a spiral bacterium associated with gastric diseases, is a topic that has been intensively discussed in last decades. Recent discoveries indicate promising antimicrobial and antibiotic-potentiating propert
Externí odkaz:
https://doaj.org/article/2feffa5a985f4a0caca90be3def8802a
Autor:
Dorota Kujawa, Lukasz Laczmanski, Slawomir Budrewicz, Anna Pokryszko-Dragan, Maria Podbielska
Publikováno v:
Gut Microbes, Vol 15, Iss 2 (2023)
ABSTRACTMultiple sclerosis (MS) causes long-lasting, multifocal damage to the central nervous system. The complex background of MS is associated with autoimmune inflammation and neurodegeneration processes, and is potentially affected by many contrib
Externí odkaz:
https://doaj.org/article/5fa345507d8545bdbe1c2672657e13e2
Autor:
Lukasz Laczmanski, Felicja Lwow, Anna Osina, Martyna Kepska, Izabela Laczmanska, Wojciech Witkiewicz
Publikováno v:
Tumor Biology, Vol 39 (2017)
Currently higher morbidity and mortality rates are observed in cancer diseases, especially sex-dependent cancers. A positive role of endogenous vitamin D concentration in cancer diseases has been reported in many publications. Furthermore, there has
Externí odkaz:
https://doaj.org/article/0a71230ee5c24900b4ea8acf0ca86fab
Autor:
Justyna Kuliczkowska Plaksej, Lukasz Laczmanski, Andrzej Milewicz, A. Lenarcik-Kabza, Anna Trzmiel-Bira, Urszula Zaleska-Dorobisz, Felicja Lwow, Lidia Hirnle
Publikováno v:
International Journal of Endocrinology, Vol 2014 (2014)
Context. Polycystic ovary syndrome (PCOS) is frequently associated with nonalcoholic fatty liver disease (NAFLD). The endocannabinoid system may play a crucial role in the pathogenesis of NAFLD. Polymorphism of the cannabinoid receptor 1 gene (CNR1)
Externí odkaz:
https://doaj.org/article/5e9c07d4416b432791550ef98899f430
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Izabela, Laczmanska, Rafal, Matkowski, Stanislaw, Supplitt, Pawel, Karpinski, Mariola, Abrahamowska, Lukasz, Laczmanski, Adam, Maciejczyk, Ewelina, Czykalko, Ewelina, Iwaneczko, Piotr, Kasprzak, Bartłomiej, Szynglarewicz, Maria, Sasiadek
Publikováno v:
Breast Cancer Research & Treatment; Dec2024, Vol. 208 Issue 3, p501-510, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
DOROTA PAWELKA, IZABELA LACZMANSKA, PAWEL KARPINSKI, STANISLAW SUPPLITT, WOJCIECH WITKIEWICZ, BARŁOMIEJ KNYCHALSKI, JOANNA PELAK, PAULINA ZEBROWSKA, LUKASZ LACZMANSKI
Publikováno v:
Cancer Genomics Proteomics
Background: The stage of colorectal cancer (CRC) at the day of diagnosis has the greatest influence on survival rate. Thus, for CRC, which is mainly identified as advanced disease, non-invasive, molecular blood or stool tests could boost the diagnosi